Carrier Screening Market Size, Share, Growth, Trends | Report 2022-2030
The global carrier screening market was surpassed at USD 2.48 billion in 2021 and is expected to hit around USD 10.44 billion by 2030, growing at a CAGR of 17.32%from 2022 to 2030.
Carrier screening is performed to diagnose a genetic disorder. It is a genetic test conducted on the patient to identify the gene responsible for a genetic disorder or abnormal chromosomal disorder. It is also performed on the pregnant woman to find out whether the child has the disorder. The test involves the blood, tissue cells of the cheeks, or saliva samples. The disorders like sickle cell anemia, Tay-Sachs disease, cystic fibrosis, fragile X syndrome, and SMA can be identified using these tests. The carrier inherits the abnormal gene from either of the parents.
Molecular tests are performed to detect the mutation by finding the abnormalities in the DNA. Techniques such as NGS are the tools to conduct carrier screening tests. The carrier may have no signs and symptoms of illness. The test is recommended for pregnant women to check whether the baby will have a chance of genetic deformities. It is also advised to the male parent of the child to undergo the carrier screening test. The early disease diagnosis and prevention of these genetic deformities fuel the market growth. For instance, in June 2019, QIAGEN launched an expanded carrier screening panel QIAseq. It is used to detect more than 200 diseases by providing information about the targets and genes.
The increasing application of genetic tests spurs the increase in funding by the government and private bodies which drives the market. Moreover, the screening tests are cost-effective which is one of the key drivers. The key players in the market have opted for various collaborations, mergers, and acquisitions leading to the development of the R&D sector. This enhances the molecular testing market. Increasing launch of novel tests for better diagnosis and treatment footholds the global market. The increasing prevalence of genetic as well as chronic diseases is a driving factor for the growth of the market globally.
Scope of The Report
| Report Coverage | Details |
| Market Size in 2021 | USD 2.48 billion |
| Revenue Forecast by 2030 | USD 10.44 billion |
| Growth rate from 2022 to 2030 | CAGR of 17.32% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segmentation | Type, Technology, End-user, Region |
| Companies Covered |
Fulgent Genetics, Illumina, Inc., Eurofins Scientific, OPKO Health, Invitae Corporation, Quest Diagnostics Thermo Fisher Scientific, Inc., Luminex Corporation, Myriad Genetics, Sema4, Abbott Laboratories, Danaher Corporation, F. Hoffmann La-Roche Ltd., others |
The market is segmented based on type, technology, application, end-user, and region segment. The type segment is further divided into expanded carrier screening which contains customized panel testing, predesigned panel testing, and targeted disease carrier screening. The technology segment is divided into DNA sequencing, PCR, and microarrays. The end-user segment is divided into hospitals and clinics, reference laboratories, physicians' offices, and others. The region segment is divided into North America, Europe, Asia-Pacific, Latin America, the Middle East & Africa.
Based on the region, North America has captured the largest market share in 2021. This is due to the presence of a well-established healthcare system in this region. Moreover, the presence of the majority of key players in North America is an additional advantage for market growth. US and Canada have a developed and advanced R&D sector for NGS, carrier screening, and molecular testing. Due to this, there is more awareness among the population about chromosomal disorder and their prevention which boosts the market. North America also accounts for a higher number of neurological and hematological disorders which fuels the necessity for screening tests.
Key Players
Market Segmentation
By Type Outlook
By Technology Outlook
By End-user Outlook
By Regional Outlook
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Carrier Screening Market
5.1. COVID-19 Landscape: Carrier Screening Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Carrier Screening Market, By Type
8.1. Carrier Screening Market, by Type, 2022-2030
8.1.1 Expanded Carrier Screening
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Targeted Disease Carrier Screening
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Carrier Screening Market, By Technology
9.1. Carrier Screening Market, by Technology, 2022-2030
9.1.1. DNA Sequencing
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Polymerase Chain Reaction
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Microarrays
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Carrier Screening Market, By End-user
10.1. Carrier Screening Market, by End-user, 2022-2030
10.1.1. Hospitals and Clinics
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Reference Laboratories
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Physicians’ Offices
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Carrier Screening Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Type (2017-2030)
11.1.2. Market Revenue and Forecast, by Technology (2017-2030)
11.1.3. Market Revenue and Forecast, by End-user (2017-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Type (2017-2030)
11.1.4.2. Market Revenue and Forecast, by Technology (2017-2030)
11.1.4.3. Market Revenue and Forecast, by End-user (2017-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Type (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Technology (2017-2030)
11.1.5.3. Market Revenue and Forecast, by End-user (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Type (2017-2030)
11.2.2. Market Revenue and Forecast, by Technology (2017-2030)
11.2.3. Market Revenue and Forecast, by End-user (2017-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Type (2017-2030)
11.2.4.2. Market Revenue and Forecast, by Technology (2017-2030)
11.2.4.3. Market Revenue and Forecast, by End-user (2017-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Type (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Technology (2017-2030)
11.2.5.3. Market Revenue and Forecast, by End-user (2017-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Type (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Technology (2017-2030)
11.2.6.3. Market Revenue and Forecast, by End-user (2017-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Type (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Technology (2017-2030)
11.2.7.3. Market Revenue and Forecast, by End-user (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Type (2017-2030)
11.3.2. Market Revenue and Forecast, by Technology (2017-2030)
11.3.3. Market Revenue and Forecast, by End-user (2017-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Type (2017-2030)
11.3.4.2. Market Revenue and Forecast, by Technology (2017-2030)
11.3.4.3. Market Revenue and Forecast, by End-user (2017-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Type (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Technology (2017-2030)
11.3.5.3. Market Revenue and Forecast, by End-user (2017-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Type (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Technology (2017-2030)
11.3.6.3. Market Revenue and Forecast, by End-user (2017-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Type (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Technology (2017-2030)
11.3.7.3. Market Revenue and Forecast, by End-user (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Type (2017-2030)
11.4.2. Market Revenue and Forecast, by Technology (2017-2030)
11.4.3. Market Revenue and Forecast, by End-user (2017-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Type (2017-2030)
11.4.4.2. Market Revenue and Forecast, by Technology (2017-2030)
11.4.4.3. Market Revenue and Forecast, by End-user (2017-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Type (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Technology (2017-2030)
11.4.5.3. Market Revenue and Forecast, by End-user (2017-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Type (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Technology (2017-2030)
11.4.6.3. Market Revenue and Forecast, by End-user (2017-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Type (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Technology (2017-2030)
11.4.7.3. Market Revenue and Forecast, by End-user (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Type (2017-2030)
11.5.2. Market Revenue and Forecast, by Technology (2017-2030)
11.5.3. Market Revenue and Forecast, by End-user (2017-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Type (2017-2030)
11.5.4.2. Market Revenue and Forecast, by Technology (2017-2030)
11.5.4.3. Market Revenue and Forecast, by End-user (2017-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Type (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Technology (2017-2030)
11.5.5.3. Market Revenue and Forecast, by End-user (2017-2030)
Chapter 12. Company Profiles
12.1. Fulgent Genetics
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Illumina, Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Eurofins Scientific
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. OPKO Health
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Invitae Corporation
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Quest Diagnostics Thermo Fisher Scientific, Inc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Luminex Corporation
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Myriad Genetics
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Sema4
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Abbott Laboratories
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers